MICROMET, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2009-11-27: Form 8-K; Period of report 2009-11-23; Description 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events; Details 1.01.
- 2009-11-05: Form 8-K; Period of report 2009-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2009-11-05: Form 8-K; Period of report 2009-11-04; Description 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 8.01 Other Events; Details 1.01.
- 2009-11-03: Form 8-K; Period of report 2009-10-28; Description 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2009-11-27 | 8-K | 2009-11-23 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 On November 24, 2009, the Company issued a press release announcing the Company’s entry into an agreement for the process development and manufacture of blinatumomab with Lonza, a copy of which is attached hereto as Exhibit 99.1. | v167618_8k.htm |
| 2009-11-05 | 8-K | 2009-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2009, Micromet, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the three and nine months ended September 30, 2009. | v164179_8k.htm |
| 2009-11-05 | 8-K | 2009-11-04 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 1.02 The information set forth in Item 1.01 above is incorporated herein by reference. 8.01 On November 5, 2009, Micromet issued a press release announcing the entry into the 2009 Agreement and the termination of the 2003 Agreement, a copy of which is attached to this report as Exhibit 99.1. | v164465_8k.htm |
| 2009-11-03 | 8-K | 2009-10-28 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 On October 29, 2009, the Company issued a press release announcing the Company’s entry into the Agreement with Sanofi, a copy of which is attached hereto as Exhibit 99.1. | v164180_8k.htm |
| 2009-08-06 | 8-K | 2009-08-06 | 2.02 Results of Operations and Financial Condition | 2.02 On August 6, 2009, Micromet, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended June 30, 2009. | v156685_8-k.htm |
| 2009-07-30 | 8-K | 2009-07-30 | 1.01 Entry into a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 2.02 The Company’s cash, cash equivalents and short-term investments available for sale was approximately $49.2 million as of June 30, 2009. 8.01 The information set forth in Item 1.01 with respect to the offering is hereby incorporated herein by reference. | v155961_8k.htm |
| 2009-07-10 | 8-K | 2009-07-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (b) On July 6, 2009, Dr. Carsten Reinhardt resigned as senior vice president and chief medical officer of Micromet, Inc. (the “Company”), with such resignation to be effective at the close of business on September 30, 2009 (the “Separation Date”). | v154364_8-k.htm |
| 2009-05-06 | 8-K | 2009-05-06 | 2.02 Results of Operations and Financial Condition | 2.02 On May 6, 2009, Micromet, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended March 31, 2009. | v148206_8-k.htm |
| 2009-03-12 | 8-K | 2009-03-12 | 2.02 Results of Operations and Financial Condition | 2.02 On March 12, 2009, Micromet, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter and fiscal year ended December 31, 2008. | v142689_8-k.htm |
| 2009-02-23 | 8-K | 2009-02-18 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 Effective as of February 18, 2009, the Board of Directors (the “Board”) of Micromet, Inc. (the “Company”), acting upon the recommendation of the Nominating/Corporate Governance Committee of the Board, appointed Dr. Kapil Dhingra as a member of the Board. 8.01 On February 23, 2009, the Company issued a press release announcing the appointment of Kapil Dhingra to the Board, a copy of which is attached hereto as Exhibit 99.1. | v141079_8k.htm |
| 2009-01-14 | 8-K | 2009-01-12 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 On January 12, 2009, the Company issued a press release announcing the Company’s entry into the Option, Collaboration and License Agreement with Bayer Schering Pharma, a copy of which is attached hereto as Exhibit 99.1. | v137089_8k.htm |